On March 5, 2026, the Patented Medicine Prices Review Board (PMPRB or Board) published a series of proposed Practice Directions to streamline its hearing process. The proposed Practice Directions signal an important procedural shift away from live in-person, “action”-style hearings in favour of paper-based “application”-style hearings. This change, to facilitate shorter and less complex hearings, suggests the
